Infectious Diseases Society of America

COVID-19 Treatment Guideline co-authors Rajesh Gandhi, MD, FIDSA of Harvard University and Adarsh Bhimraj, MD, FIDSA of the Cleveland Clinic give an update on COVID-19 therapeutics and discuss two recently published papers in Clinical Infectious Diseases.

Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatment guideline panel:

Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords:

Direct download: Dec_4_-_Theurapeutics_Update_mixdown.mp3
Category:medicine -- posted at: 10:00pm PST